In Vivo Induction of the Lymphokine-activated Killer Phenomenon: Interleukin 2-dependent Human Non-Major Histocompatibility Complex-restricted Cytotoxicity Generated in Vivo during Administration of Human Recombinant Interleukin 21
Cancer Res (1988) 48 (7): 1965–1971.
Currently there are no citedby results. Try again later.
